Your session is about to expire
← Back to Search
Diagnostic Device
ANNE Sleep for Sleep Apnea
N/A
Waitlist Available
Research Sponsored by Northwestern University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4 nights
Awards & highlights
No Placebo-Only Group
Summary
This trial tests ANNE, a new tool for diagnosing sleep problems, in people with moderate to severe OSA, especially those aged 65 and older. It aims to see if ANNE works as well as current methods and if it is easier to use.
Eligible Conditions
- Sleep Apnea
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 4 nights
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4 nights
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Percent Agreement of ANNE Sleep System to Home Sleep Test (WatchPAT) for Diagnostic Performance to Detect Moderate to Severe Obstructive Sleep Apnea.
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: ANNE SleepExperimental Treatment1 Intervention
After consent, subjects will wear the ANNE Sleep system with HST for 1 night and 3 nights with ANNE sleep system alone.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
ANNE Sleep
2022
N/A
~330
Find a Location
Who is running the clinical trial?
Sibel HealthUNKNOWN
1 Previous Clinical Trials
287 Total Patients Enrolled
Northwestern UniversityLead Sponsor
1,640 Previous Clinical Trials
957,534 Total Patients Enrolled
2 Trials studying Sleep Apnea
174 Patients Enrolled for Sleep Apnea
Sibel Health Inc.Industry Sponsor
4 Previous Clinical Trials
339 Total Patients Enrolled
Share this study with friends
Copy Link
Messenger